Related Experiment Videos
The superiority of cold oxygenated dilute blood cardioplegia
Insights
Oxygenated dilute blood cardioplegia significantly improves heart protection during surgery compared to cold crystalloid solutions. This method reduces the need for mechanical support and lowers the incidence of heart muscle damage.
Area of Science:
- Cardiovascular Surgery
- Myocardial Preservation
- Cardioplegia
Background:
- Oxygenation of crystalloid cardioplegic solutions enhances myocardial preservation.
- Addition of red blood cells improves capillary perfusion.
- Shift from cold crystalloid to cold oxygenated dilute blood cardioplegia implemented.
Purpose of the Study:
- Evaluate the clinical effectiveness of cold oxygenated dilute blood cardioplegia.
- Compare myocardial protection with cold crystalloid cardioplegia.
Main Methods:
- Retrospective analysis of 400 operative procedures.
- Comparison of 200 patients receiving cold crystalloid solution (Group 1) vs. 200 receiving cold oxygenated dilute blood (Group 2).
Main Results:
- Group 2 showed reduced need for intraaortic balloon pump and atrioventricular pacing.
- Lower incidence of perioperative myocardial infarction in Group 2.
- No electrocardiographic evidence of perioperative infarction in Group 2 patients.
Conclusions:
- Cold oxygenated dilute blood cardioplegia offers superior myocardial preservation during ischemic arrest.
- Enhanced oxygen delivery and capillary perfusion contribute to improved outcomes.
- This method provides better protection than non-oxygenated crystalloid solutions.
Abstract:
It has been clearly shown, both in a laboratory model and in humans, that oxygenation of crystalloid cardioplegic solutions markedly enhances myocardial preservation. The addition of a small volume of red cells to a crystalloid perfusate improves capillary perfusion. Based on these results, we have changed our cardioplegic solution from cold crystalloid to cold oxygenated dilute blood. In the present study we retrospectively evaluate the results of 400 operative procedures to determine whether the addition of oxygenation and a small volume of blood to the cardioplegic solution enhances myocardial protection in the clinical setting. Two hundred consecutive patients who underwent operation with cardioplegic arrest using a cold crystalloid cardioplegic solution (group 1) were compared with a subsequent 200 patients who underwent operation with cold oxygenated dilute blood cardioplegia (group 2). Patients in group 2, who received cold oxygenated dilute blood cardioplegia, had a significantly reduced need for postoperative intraaortic balloon pump counterpulsation and for atrioventricular pacing. Also, patients in group 2 had a lower incidence of perioperative myocardial infarction and had improved early outcome. None of the 200 patients in group 2 had electrocardiographic evidence of perioperative infarction. We conclude that cold oxygenated dilute blood cardioplegia provides better preservation than does a nonoxygenated crystalloid solution during elective ischemic arrest, because a cold crystalloid solution is able to deliver oxygen and the red cells are able to enhance capillary perfusion.